封面
市場調查報告書
商品編碼
1705899

CRISPR 技術市場:市場規模、佔有率、前景、按產品、應用、最終用戶和地區分類的機會分析(2025 年至 2032 年)

CRISPR Technology Market, By Product, By Application, By End User, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032

出版日期: | 出版商: Coherent Market Insights | 英文 169 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球 Crispr 技術市場規模估計為 36.562 億美元,預計到 2032 年將達到 126.493 億美元,2025 年至 2032 年的年複合成長率(CAGR)為 19.4%。

報告範圍 報告詳細資訊
基準年 2024 2025年的市場規模 36.562億美元
效能數據 從2020年到2024年 預測期 2025年至2032年
預測期:2025-2032年複合年成長率: 19.40% 2032年價值預測 126.493億美元
數字。 2025 年 Crisprun 技術市場佔有率(按地區)
CRISPR技術市場-IMG1

CRISPR技術正在推動醫學、製藥、生物技術和農業領域基因組編輯的進步,使世界各地的科學家能夠透過更快、更有效率的基因組編輯來進行這些領域的研究。 CRISPR 也被用於糾正基因缺陷、治療人類疾病和收穫更好的作物品種。 CRISPR 有許多潛在的應用,包括治療或預防疾病傳播、糾正基因缺陷和改良作物。 CRISPR-Cas9系統有廣泛的應用。在醫學上,它用於癌症、病毒感染、遺傳疾病和病原體檢測的研究。 CRISPR 是一種有可能改變世界的基因編輯技術。

市場動態:

全球範圍內的 COVID-19 疫情爆發、正在進行的臨床試驗的增加以及對基因編輯工具的研究不斷擴展是預計在預測期內促進全球 CRISPR 技術市場成長的關鍵因素。例如,2020 年 3 月,多倫多大學的科學家開發了 CHyMErA,這是一種基於 CRISPR 的更通用的基因組編輯工具。

CRISPR技術在COVID-19的防治上具有巨大的應用潛力。 2020 年 3 月,紐約基因組中心的研究人員開發了一種新的 CRISPR篩檢技術,該技術針對 RNA,包括新型病毒(COVID-19)的 RNA。此外,2020 年 11 月,蘇黎世瑞士聯邦理工學院的研究人員以 CAS12a 取代了 CAS9 酶,使他們能夠在 25 個目標位點編輯基因。

本研究的主要特點

  • 本報告對全球 CRISPR 技術市場進行了詳細分析,並提供了預測期(2025-2032 年)的市場規模和年複合成長率(CAGR),假設基準年為 2024 年。
  • 它還揭示了不同領域的潛在商機,並說明了該市場的有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
  • 全球 CRISPR 技術市場的主要企業會根據以下參數進行分析,例如公司亮點、產品系列、關鍵亮點、財務表現和策略。
  • 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 全球 CRISPR 技術市場報告迎合了該行業的各個相關人員,包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員可以透過用於分析全球 CRISPR 技術市場的各種策略矩陣更輕鬆地做出決策。

目錄:

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
    • CRISPR 的需求和應用不斷成長
    • CRISPR的高成本
    • COVID-19(全球大流行)疫情
  • 影響分析
  • 主要亮點
  • 監管情景
  • 產品發布/核准
  • PEST分析
  • 波特分析
  • 併購場景

4.全球CRISPR 技術市場 - 冠狀病毒 (COVID-19) 大流行的影響

  • COVID-19流行病學
  • 供需側分析
  • 經濟影響

5. 2020 年至 2032 年全球 CRISPR 技術市場(依產品分類)

  • 酵素
  • 套件和試劑
  • 嚮導RNA
  • 其他

6.全球CRISPR 技術市場(按應用分類),2020 年至 2032 年

  • 生物醫學
  • 農業
  • 產業
  • 其他

7. 2020 年至 2032 年全球 CRISPR 技術市場(按最終用戶分類)

  • 製藥和生物技術公司
  • 學術和政府研究組織
  • 其他(CRO等)

8. 2020 年至 2032 年全球 CRISPR 技術市場(按地區)

  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲
  • 其他國家

第9章 競爭態勢

  • Merck KGaA
  • Thermo Fisher Scientific
  • Origene Technologies, Inc.
  • New England Biolabs
  • GenScript
  • GeneCopoeia, Inc.
  • Cellecta, Inc.
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc.(Horizon Discovery Ltd.)
  • Danaher Corporation(Integrated DNA Technologies)

第 10 章分析師建議

  • 命運之輪
  • 分析師觀點
  • 一致的機會圖

第 11 章 章節

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI5175

Global Crispr Technology Market is estimated to be valued at USD 3,656.2 Mn in 2025 and is expected to reach USD 12,649.3 Mn by 2032, growing at a compound annual growth rate (CAGR) of 19.4% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 3,656.2 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 19.40% 2032 Value Projection: USD 12,649.3 Mn
Figure. Crispr Technology Market Share (%), By Region 2025
CRISPR Technology Market - IMG1

CRISPR technology is driving advances in genome editing across medicine, pharmaceutical, biotechnology, and agriculture, which has enabled scientists to conduct research in these fields through faster and more efficient genome editing across the world. CRISPR is also used to correct genetic defects, treat human diseases, and yield better crop varieties. It has a number of potential applications that include treating and preventing the spread of diseases, correcting genetic defects, and also, improving crops. The CRISPR-Cas9 system has a wide diversity of applications. In medicine, it has been applied in research related to cancer, virus infections, genetic diseases and detection of pathogens. CRISPR is a technology that can be used to edit genes and, as such, will likely change the world.

Market Dynamics:

The outbreak of COVID-19 across the globe, increasing number of ongoing clinical trials, and expanding research in gene editing tools are some major factors expected to augment growth of the global CRISPR Technology market during the forecast period. For instance, in March 2020, scientists at the University of Toronto developed CHyMErA, a CRISPR-based tool for more versatile genome editing.

CRISPR technology have great potential for application in both the prevention and control of COVID-19. In March 2020, researchers at New York genome center developed a new CRISPR screening technology to target RNA, including RNA of novel viruses (COVID-19). Moreover, in November 2020, researchers at ETH Zurich, Switzerland, swapped CAS9 enzyme for CAS 12a, which allowed the researchers to edit genes in 25 target sites.

Key features of the study:

  • This report provides in-depth analysis of the global CRISPR Technology market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global CRISPR Technology market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Merck KGaA, Thermo Fisher Scientific, Origene Technologies, Inc., New England Biolabs, GenScript, GeneCopoeia, Inc., Cellecta, Inc., Agilent Technologies, Inc., PerkinElmer, Inc. (Horizon Discovery Ltd.), and Danaher Corporation (Integrated DNA Technologies), among others
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global CRISPR Technology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global CRISPR Technology market.

Detailed Segmentation:

  • Global CRISPR Technology Market, By Product:
    • Enzymes
    • Kits & Reagents
    • Guide RNA
    • Others
  • Global CRISPR Technology Market, By Application:
    • Biomedical
    • Agricultural
    • Industrial
    • Others
  • Global CRISPR Technology Market, By End User:
    • Pharmaceutical companies and Biotechnology Companies
    • Academics and Government Research Institutes
    • Others (CROs etc.)
  • Global CRISPR Technology Market, By Geography:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • Merck KGaA
    • Thermo Fisher Scientific
    • Origene Technologies, Inc.
    • New England Biolabs
    • GenScript
    • GeneCopoeia, Inc.
    • Cellecta, Inc.
    • Agilent Technologies, Inc.
    • PerkinElmer, Inc. (Horizon Discovery Ltd.)
    • Danaher Corporation (Integrated DNA Technologies)

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rising demand and adoption of CRISPR
    • High cost of CRISPR
    • The outbreak of COVID-19 (global pandemic)
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global CRISPR Technology Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global CRISPR Technology Market, By Product, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Enzymes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Kits & Reagents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Guide RNA
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global CRISPR Technology Market, Application, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Biomedical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Agricultural
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Industrial
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global CRISPR Technology Market, By End User, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Pharmaceutical companies and Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Academics and Government Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others (CROs etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Global CRISPR Technology Market, By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Rest of World
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)

9. Competitive Landscape

  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Origene Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • New England Biolabs
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GenScript
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GeneCopoeia, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cellecta, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Agilent Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • PerkinElmer, Inc. (Horizon Discovery Ltd.)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Danaher Corporation (Integrated DNA Technologies)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

10. Analyst Recommendation

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. Section

  • References
  • Research Methodology
  • About Us and Sales Contact